Harel Insurance Investments & Financial Services Ltd.
InsurancePosition in LLY — ELI LILLY & Co
CIK 1429390
Ramat Gan, L3
Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,832,729
+$841,217 QoQ
Shares Held
1,528
+41.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,567
of 4,605 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Harel Insurance Investments & Financial Services Ltd. holds $7,318,560 across 9 Drug Manufacturers - General names. LLY ranks #2 (25.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,576 | $1,924,076 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
1,528 | $1,832,729 | |
| 3 | NVS |
Novartis AG
|
11,662 | $1,827,668 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,490 | $576,965 | |
| 5 | NVO |
Novo Nordisk A S
|
9,962 | $477,578 | |
| 6 | ABBV |
AbbVie Inc.
|
900 | $226,476 | |
| 7 | AMGN |
Amgen Inc
|
500 | $181,060 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,200 | $151,608 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,832,729 | 1,528 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $991,512 | 1,078 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $670,600 | 624 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $867,531 | 1,137 | Shares | Defined | 2025-10-29 | |
| 2025-06-30 | $602,576 | 773 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $422,040 | 511 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $250,900 | 325 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $359,691 | 406 | Shares | Defined | 2024-10-15 | |
| 2024-06-30 | $248,979 | 275 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $413,874 | 532 | Shares | Defined | 2024-04-30 | |
| 2023-09-30 | $323,889 | 603 | Shares | Defined | 2023-10-30 | |
| 2023-03-31 | $461,899 | 1,345 | Shares | Defined | 2023-05-02 | |
| 2022-12-31 | $111,581 | 305 | Shares | Defined | 2023-01-26 | |
| 2022-09-30 | $712,016 | 2,202 | Shares | Defined | 2022-10-31 | |
| 2022-06-30 | $129,692 | 400 | Shares | Defined | 2022-07-19 | |
| 2022-03-31 | $2,004,590 | 7,000 | Shares | Defined | 2022-05-03 | |
| 2021-12-31 | $3,590,860 | 13,000 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $3,110,626 | 13,463 | Shares | Defined | 2021-10-25 | |
| 2021-06-30 | $489,795 | 2,134 | Shares | Defined | 2021-07-26 | |
| 2021-03-31 | $492,644 | 2,637 | Shares | Defined | 2021-04-27 | |
| 2020-12-31 | $2,026,080 | 12,000 | Shares | Defined | 2021-01-26 | |
| 2020-09-30 | $1,770,171 | 11,959 | Shares | Defined | 2020-10-20 | |
| 2020-06-30 | $59,597 | 363 | Shares | Defined | 2020-07-14 | |
| 2020-03-31 | $33,708 | 243 | Shares | Defined | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||